欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体
Anti-M1R mAbs [M1R-01](MABL-3618)
  • Anti-M1R mAbs [M1R-01](MABL-3618)

Anti-M1R mAbs [M1R-01](MABL-3618)

简要描述:

For Research Use Only. Not for diagnostic or therapeutic use.

产品参数:

Cat. No.:MABL-3618

Application:in vivo, neutralizing, SPR

Isotype:Engineer antibody

Species Reactivity:Monkeypox virus, Vaccinia virus

Clone No.:M1R-01

产品价格:¥0

详细介绍
Cat. No.
MABL-3618
Application
in vivo, neutralizing, SPR
Isotype
Engineer antibody
Species Reactivity
Monkeypox virus, Vaccinia virus
Clone No.
M1R-01
From
Recombinant Antibody
Specificity
The original antibody specifically targets the core antigen M1R of the monkeypox virus. The antibody binds to a conformational epitope encompassing α3 (A94–L95), α4 (Y111 and T113), α5 (N157, C158, K161, and Q165), α4' (V121) the loop connecting α4' and β3 (N130), β3 (V131–133), β4 (F148), along with the sporadic residues I38, N96, D134 on M1R protein. The antibody cross reacts with the vaccinia virus.
Alternative Names
M1-01; M1R protein; Entry-fusion complex associated protein OPG095; EFC-associated protein OPG095; Protein L1
UniProt
M1LBP0
Immunogen
The original antibody was generated by panning a nanobody display library against M1R.
Application Notes
The binding affinity of the original format of the antibody and the mouse Fc version of the antibody to M1R protein was measured by surface plasmon resonance (Kd= 43 nM and 1.79 nM respectively). Neutralization activity of the original format of the antibody and the murine Fc version of the antibody was tested on BS-C-1 cells infected with VACV. The neutralization NT 50 value of the original fragment was 28.04 μg/mL, and the neutralization NT 50 value of the mFc fusion variant of the antibody was 1.99 μg/mL (CN120329422A). The crystal structure of the antibody in complex with M1R protein was determined. Binding affinity of the original format of the antibody and mFc formats of the antibody were measured by SPR analysis (Kd = 40.38 nM and 1.79 nM respectively). The two variants could neutralize the intracellular mature virions of modified vaccinia Ankara (MVA) (IC50 = 16.14 for the original format of the antibody and 2.22 for the mFc version) and VACV-WR (IC50 = 26.47 for the original format of the antibody and 3.13 for the mFc version). Further, the mFc variant could neutralize MPXV (IC50= 67.24 respectively). Intraperitoneal injection of the human IgG1-Fc fusion version of the antibody protected mice from fatal VACV challenge. Studies were conducted with the bivalent and trivalent versions of the antibody (Yang et al., 2025; PMID: 40133273). These versions are available upon request.
Antibody First Published
Yang et al. Identification of neutralizing nanobodies protecting against poxvirus infection Cell Discov. 2025 Mar 25;11(1):31. doi: 10.1038/s41421-025-00771-7. PMID:40133273
Note on publication
The original paper describes the generation and characterization of the antibody.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.

 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号